Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats

Journal of Biochemical and Molecular Toxicology

Volumn 14, Issue 6, 2000, Pages 329-334

  Rauscher, Frederick M ^a   Sanders, Ruth A ^a   Watkins III, John B ^a  

^a Indiana University School of Medicine   (United States)

Author keywords

Brain; Diabetes; Heart; Kidney; Liver; Oxidative Stress; Piperine; Reactive Oxygen Species

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; ANTIOXIDANT; ENZYME INHIBITOR; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PIPERIDINE DERIVATIVE; PIPERINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HEART; HEART MUSCLE; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; RAT; REFERENCE VALUE; SPRAGUE DAWLEY RAT;

ALKALOIDS; ANIMALS; ANTIOXIDANTS; BENZODIOXOLES; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEART; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; MYOCARDIUM; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034571975     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0461(2000)14:6<329::AID-JBT5>3.0.CO;2-G     Document Type: Article

References (10)

1. Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmaco-kinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991;41:615-617.
2. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-356.
3. Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 1985;232:258-262.
4. Dalvi RR, Dalvi PS. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats. Drug diem Toxicol 1991;14:219-229.
5. Kang MH, Won SM, Park SS, Kim SG, Novak RF, Kim ND. Piperine effects on the expression of P4502E1, P4502B, and P4501A in rat. Xenobiotica 1994;24:1195-1204.
6. Reen RK, Jamwal DS, Taneja SC, Koul JL, Dubey RK, Wiebel FJ, Singh J. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem Pharmacol 1993;46:229-238.
7. Singh J, Dubey RK, Atal CK. Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogenous UDP-glucuronic acid content. J Pharmacol Exp Ther 1986;236:488-493.
8. Dhuley JN, Raman PH, Mujumdar AM, Naik SR. Inhibition of lipid peroxidation by piperine during experimental inflammation in rats. Indian J Exp Biol 1993; 31:443-445.
9. Koul IB, Kapil A. Evaluation of the liver protective potential of piperine, an active principle of black and long peppers. Planta Med 1993;59:413-417.
10. Khajuria A, Thusu N, Zutshi U, Bedi KL. Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa. Mol Cell Biochem 1998;189:113-118.